A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
-
Published:2024-08
Issue:
Volume:194
Page:107870
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Kim Yu Jung,
Kim Soyeon,
Kim Tae Min,
Suh Koung Jin,
Kim Miso,
Kim Se Hyun,
Keam Bhumsuk,
Kim Dong-WanORCID,
Lee Jong Seok,
Heo Dae Seog